These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 21364183)

  • 1. Toward developing a scale to empirically measure psychotic defense mechanisms.
    Constantinides P; Beck SM
    J Am Psychoanal Assoc; 2010 Dec; 58(6):1159-88. PubMed ID: 21364183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying psychotic defenses in a clinical interview.
    Berney S; de Roten Y; Beretta V; Kramer U; Despland JN
    J Clin Psychol; 2014 May; 70(5):428-39. PubMed ID: 24691714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Changes in defense mechanisms resulting from a Day Treatment Center therapy in persons suffering from psychotic disorders].
    Cichocki L
    Psychiatr Pol; 2008; 42(1):47-57. PubMed ID: 18567403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Specificities of defense mechanisms in bipolar affective disorder: relations with symptoms and therapeutic alliance.
    Kramer U; de Roten Y; Perry JC; Despland JN
    J Nerv Ment Dis; 2009 Sep; 197(9):675-81. PubMed ID: 19752647
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Actual approaches to post-psychotic depression].
    Eiber R; Even C
    Encephale; 2001; 27(4):301-7. PubMed ID: 11686051
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanisms of defense: development and research perspectives.
    Kernberg PF
    Bull Menninger Clin; 1994; 58(1):55-87. PubMed ID: 8167613
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An empirical approach to the study of defense mechanisms: I. Reliability and preliminary validity of the Rorschach Defense scales.
    Cooper SH; Perry JC; Arnow D
    J Pers Assess; 1988; 52(2):187-203. PubMed ID: 3404385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of the TAT to measure change in defense mechanisms following intensive psychotherapy.
    Cramer P; Blatt SJ
    J Pers Assess; 1990; 54(1-2):236-51. PubMed ID: 2313545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a Q-sort version of the Defense Mechanism Rating Scales (DMRS-Q) for clinical use.
    Di Giuseppe M; Perry JC; Petraglia J; Janzen J; Lingiardi V
    J Clin Psychol; 2014 May; 70(5):452-65. PubMed ID: 24706519
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Empirical studies of defense style: relationships with psychopathology and change.
    Bond M
    Harv Rev Psychiatry; 2004; 12(5):263-78. PubMed ID: 15590575
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Clinical aspects of depression in the psychotic patient].
    Azorin JM; Blin O; Philippot P
    Encephale; 1994 Dec; 20 Spec No 4():663-6. PubMed ID: 7895633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessment of insight in psychotic disorders.
    Fennig S; Naisberg-Fennig S; Craig TJ
    Isr J Psychiatry Relat Sci; 1996; 33(3):175-87. PubMed ID: 9009517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dimensions of delusional experience scale: a psychometric evaluation of a german version.
    Büche L; Gentner NC; Kaiser S; von Bock A; Grupe S; Joest K; Barthel A; Vedder H; Mundt C; Kronmüller KT
    Psychopathology; 2010; 43(3):189-96. PubMed ID: 20375541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Intolerance of ambiguity in affective and schizophrenic disorders].
    Heerlein A; Richter P
    Nervenarzt; 1991 May; 62(5):269-73. PubMed ID: 1865955
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Psychometric Properties of the Defense Mechanisms Rating Scales-Self-Report-30 (DMRS-SR-30): Internal Consistency, Validity and Factor Structure.
    Prout TA; Di Giuseppe M; Zilcha-Mano S; Perry JC; Conversano C
    J Pers Assess; 2022; 104(6):833-843. PubMed ID: 35180013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a multidimensional measure for recurrent abdominal pain in children: population-based studies in three settings.
    Malaty HM; Abudayyeh S; O'Malley KJ; Wilsey MJ; Fraley K; Gilger MA; Hollier D; Graham DY; Rabeneck L
    Pediatrics; 2005 Feb; 115(2):e210-5. PubMed ID: 15687428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Italian version of the Defense Mechanisms Rating Scales for Clinicians: a tool for the assessment of defense mechanisms in medical oncology].
    Piccinelli C; Giannini M; Rusignuolo I; Gori A; Clerici CA; Vegni EA; Despland JN
    Recenti Prog Med; 2014 Nov; 105(11):429-36. PubMed ID: 25424237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A study of stability and change in defense mechanisms during a brief psychodynamic investigation.
    Drapeau M; De Roten Y; Perry JC; Despland JN
    J Nerv Ment Dis; 2003 Aug; 191(8):496-502. PubMed ID: 12972851
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scales to assess psychosis in Parkinson's disease: Critique and recommendations.
    Fernandez HH; Aarsland D; Fénelon G; Friedman JH; Marsh L; Tröster AI; Poewe W; Rascol O; Sampaio C; Stebbins GT; Goetz CG
    Mov Disord; 2008 Mar; 23(4):484-500. PubMed ID: 18175343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Psychotic-like experiences, appraisals, and trauma.
    Lovatt A; Mason O; Brett C; Peters E
    J Nerv Ment Dis; 2010 Nov; 198(11):813-9. PubMed ID: 21048472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.